Georgios Ponirakis, PhD 🇺🇦 retweetledi
Georgios Ponirakis, PhD 🇺🇦
512 posts

Georgios Ponirakis, PhD 🇺🇦
@GPonirakis
Researcher @WCMQatar tweets about corneal confocal microscopy #CCM research a diagnostic biomarker for #neurodegenerative diseases
Doha, Qatar 🇶🇦 Katılım Ekim 2013
4K Takip Edilen4.6K Takipçiler

Read the full study here: onlinelibrary.wiley.com/doi/10.1111/jn…
English

Our intuition often misleads us into thinking that general obesity carries the same risk as central obesity. Our study shows that visceral, not subcutaneous, fat drives peripheral #neuropathy through diabetes, hypertension, inflammation, and vascular disease.

English

Our latest research on CCM shows that corneal endothelial cell density is significantly reduced in dementia and is associated with cortical gray matter atrophy, while corneal nerve fiber loss is evident in both mild cognitive impairment and dementia. alz-journals.onlinelibrary.wiley.com/doi/10.1002/tr…

English

@GroupENA @Yiannaras @Rayazamalik Are the little splotches apart from the fibres on (B), langerhans cells?
English
Georgios Ponirakis, PhD 🇺🇦 retweetledi

As AI advances in the analysis of corneal nerve morphology, @Yiannaras et al., from Prof. @Rayazamalik's lab, showed that corneal confocal microscopy (CCM) can distinguish patterns of neurodegeneration in multiple sclerosis and epilepsy. Read more: pubmed.ncbi.nlm.nih.gov/39671224/

English

Great news! Our letter to the editor advocating for a “one agency” funding approach to boost peripheral neuropathy research has been accepted by the journal of @PNSociety1
Enjoyed working with all coauthors
@neuroadipo @VinceSpallone @EvaFeldmanMDPhD
Details coming soon💡📝

English

The most important meeting on diabetic neuropathy. In the world.
2025 Bucharest.
Neurodiab@Neurodiab_eu
Looking forward to seeing you at the 35th Annual Meeting of NEUROdiab - Diabetic Neuropathy Study Group 11-14 September 2025, Bucharest, Romania 2025.neurodiab.org
English

Pleasure to present on neuropathy in prediabetes & diabetes at the 29th TMIMS international symposium: a new era for diagnosis and treatment of #diabetic_neuropathy at the Tokyo Metropolitan Institute of Medical Science. Thank you Dr Odriozola & Dr Sango for the kind invitation!

English
Georgios Ponirakis, PhD 🇺🇦 retweetledi

Weight management in diabetes: study highlights neuroprotective role of weight loss medications
On Neurodiab website a signaling of articles on #diabeticneuropathy
The 149th NEUROdiab Publication News is by Mette Krabsmark Borbjerg (neurodiab.eu/publication-ne……)

English
Georgios Ponirakis, PhD 🇺🇦 retweetledi
Georgios Ponirakis, PhD 🇺🇦 retweetledi
Georgios Ponirakis, PhD 🇺🇦 retweetledi
Georgios Ponirakis, PhD 🇺🇦 retweetledi

Check out the new work from @GPonirakis and colleagues:
Glucose lowering medication associated with weight loss may limit the progression of diabetic neuropathy in type 2 diabetes
onlinelibrary.wiley.com/doi/10.1111/jn…
#JPNSXHighlights
English
Georgios Ponirakis, PhD 🇺🇦 retweetledi

@KMizokamiStout @GerryRaDrGMagic @marcosmatos_ @Lorena_Antunes @VinceSpallone Thank you, all, for a truly great #NeuroDiab2024
🇩🇰🇮🇹
@GPonirakis @Yiannaras @Rayazamalik @johanroeikjer @KenderZoltan @VinniRasmussen @MSjoegaard @MetteBorbjerg




English
Georgios Ponirakis, PhD 🇺🇦 retweetledi

Hypertriglyceridaemia in absence of diabetes causes peripheral & cardiac autonomic neuropathy.
@Neurodiab_eu
@heartukcharity
@OfficialUoM
@CVD_MFT
@MFT_Research

Rome, Lazio 🇮🇹 Română
Georgios Ponirakis, PhD 🇺🇦 retweetledi

Great work by @GPonirakis from Rayaz Malik group showing the variables associated with large and small fibre #neuropathy in people with and without T2 #diabetes . It highlights the links between visceral #obesity and health beyond BMI @Neurodiab_eu #neurodiab2024



English









